January 19, 2011 – GE Healthcare and Veran announced a strategic supplier agreement this week in which GE became the exclusive distributor and reseller of Veran’s ig4 fusion imaging angiography navigation system in the United States.
The deal brings together GE’s Innova angiography imaging systems and Veran’s electromagnetic navigation to create a comprehensive interventional oncology solution under a single point of contact. The system allows 4-D registration capability with for precise targeting of cancerous lesions.
The multimodality Veran ig4 system helps clinicians deliver instruments to small targets in difficult to access regions of the human body in order to diagnose and treat disease minimally invasively. The navigation system uses electromagnetic localization and 4-D (x, y, z time) registration to display an interventional instrument, such as a biopsy needle or ablation needle, on a computer monitor with respect to anatomic imaging and treatment planning.
This system is compatible with GE’s Innova imaging systems, which acquire CT-like patient images of the target organ(s) that can be exported to the navigation system in the same imaging suite, during the interventional procedure. The resulting displayed image provides navigation information to help physicians insert biopsy needles, ablation (radio frequency (RF), cryotherapy and microwave) probes and other devices through the skin more quickly and with greater target accuracy. Also, using Innova CT images with Veran ig4 system may help to reduce the absorbed radiation dose through decreased use of fluoroscopy.
“This is exciting news for our customers who want to perform complex procedures in a timely fashion with more confidence. The combined systems can help clinicians achieve greater accuracy, perform procedures more quickly and reduce radiation dose,” said Chantal Le Chat, general manager of interventional radiology, GE Healthcare.
”Partnering with a global company such as GE Healthcare to significantly increase the access of our cutting edge 4-D registration technology is a great step forward for Veran Medical,” said Jerome R. Edwards, president and CEO, Veran Medical Technologies. “GE Healthcare’s healthymagination vision is extremely synergistic with the mission that Veran Medical has by having its focus directed in the interventional oncology market.”
For more information: www.gehealthcare.com, www.veranmedical.com
October 07, 2026 
